Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Head & Neck 3Breast 3Other hematologic neoplasm 1

Conditions

Breast Neoplasms 3Pain 1Neoplasms 1Inflammation 1Hypertension 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Sulindac × Breast × Clear all
NCT04542135 2025-06-03

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Stony Brook University

Phase 2 Completed
62 enrolled
Breast

Breast Neoplasms

NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

NCT00039520 2014-05-06

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Fox Chase Cancer Center

Phase 2 Completed
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡